Esmolol for the management of pediatric hypertension after cardiac operations

Journal of Thoracic and Cardiovascular Surgery

Volumn 115, Issue 4, 1998, Pages 890-897

  Wiest, D B ^a   Garner, S S ^a   Uber, W E ^a   Sade, R M ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESMOLOL; NITROPRUSSIDE SODIUM;

AORTA COARCTATION; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CHILD; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; DRUG DISPOSITION; DRUG EFFICACY; FEMALE; HEART RATE; HEART SURGERY; HUMAN; HYPERTENSION; INFANT; MALE; NEWBORN; PRIORITY JOURNAL; SCHOOL CHILD; STEADY STATE; SURGICAL TECHNIQUE; SYSTOLIC BLOOD PRESSURE;

EID: 0031980173     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(98)70371-X     Document Type: Article

References (27)

1. AP Rocchini A Rosenthal AC Barger AR Castaneda AS Nadas Pathogenesis of paradoxical hypertension after coarctation resection Circulation 54 1976 382 387
2. S Fox WS Pierce JA Waldhausen Pathogenesis of paradoxical hypertension after coarctation repair Ann Thorac Surg 29 1980 135 141
3. A Applebaum EH Blackstone NT Kouchoukos JW Kirklin Afterload reduction and cardiac output in infants early after intracardiac surgery Am J Cardiol 39 1977 445 451
4. E Sumner J Stark Postoperative care J Stark M de Leval Surgery for congenital heart defects 1994 Saunders Philadelphia 193 233
5. AC Chang FL Hanley G Wernovsky Early bidirectional cavopulmonary shunt in young infants: postoperative course and early results Circulation 88 1993 149 158
6. HJ Khambatta JG Stone E Khan Hypertension during anesthesia on discontinuation of sodium nitroprusside–induced hypotension Anesthesiology 51 1979 127 130
7. PR Saxena Interaction between the renin-angiotensin-aldosterone and sympathetic nervous systems J Cardiovasc Pharmacol 19 Suppl 6 1992 S80 S88
8. CR Benedict D Phil DG Smith A Fisher Changes in plasma catecholamines and dopamine beta-hydroxylase after corrective surgery for coarctation of the aorta Circulation 57 1978 598 602
9. RJ Gray TM Bateman LS Czer C Conklin JM Matlogg Comparison of esmolol and nitroprusside for acute post-cardiac surgical hypertension Am J Cardiol 59 1987 887 891
10. RJ Gorczynski JE Shaffer RJ Lee Pharmacology of ASL-8052, a novel beta-adrenergic receptor antagonist with an ultra-short duration of action J Cardiovasc Pharmacol 5 1983 668 677
11. CY Sum A Yacobi R Kartzinel H Stampfli CS Davis CM Lai Kinetics of esmolol, an ultra-short-acting beta blocker, and of its major metabolite Clin Pharmacol Ther 34 1983 427 434
12. P Turlapaty A Laddu S Murthy B Singh R Lee Esmolol: a titratable short-acting intravenous beta blocker for acute critical care settings Am Heart J 114 1987 866 885
13. The Esmolol Research Group Intravenous esmolol for the treatment of supraventricular tachyarrhythmia: results of a multicenter, baseline-controlled safety and efficacy study in 160 patients Am Heart J 112 1986 498 505
14. JM Kirshenbaum RF Kloner N McGowan EM Antman Use of an ultrashort-acting beta-receptor blocker (esmolol) in patients with acute myocardial ischemia and relative contraindications to beta blockade therapy J Am Coll Cardiol 12 1988 773 780
15. JG Reves ND Goughwell E Hawkins Esmolol for treatment of intraoperative tachycardia and/or hypertension in patients having cardiac operations J Thorac Cardiovasc Surg 100 1990 221 227
16. DR Miller RJ Martineau J Hill Bolus administration of esmolol for controlling the haemodynamic response to tracheal intubation: the Canadian multicentre trial Can J Anaesth 38 1991 849 858
17. DB Wiest Esmolol: a review of its therapeutic efficacy and pharmacokinetic characteristics Clin Pharmacokinet 28 1995 190 202
18. JG Reves P Flezzani Perioperative use of esmolol Am J Cardiol 56 1985 57F 62F
19. DB Wiest DL Trippel PC Gillette SS Garner Pharmacokinetics of esmolol in children Clin Pharmacol Ther 49 1991 618 623
20. DL Trippel DB Wiest PC Gillette Cardiovascular and antiarrhythmic effects of esmolol in children J Pediatr 119 1991 142 147
21. BF Cuneo VR Zales PC Blahunka DW Benson Pharmacodynamics and pharmacokinetics of esmolol, a short-acting beta-blocking agent, in children Pediatr Cardiol 15 1994 296 301
22. Task Force on Blood Pressure Control in Children Report of the second task force on blood pressure control in children—1987 Pediatrics 79 1987 1 25
23. DB Wiest SS Garner LM Childress Stability of esmolol hydrochloride in 5% dextrose injection Am J Health Syst Pharm 52 1995 716 718
24. CY Quon HF Stampfli Biochemical properties of blood esmolol esterase Drug Metab Dispos 13 1985 420 424
25. R Achari D Drissel D Thomas K Shin Z Look Analysis of esmolol in human blood by high-performance liquid chromatography and its application to pharmacokinetic studies J Chromatogr 424 1988 430 434
26. M Gilbaldi D Perrier One-compartment model 2nd ed M Gilbaldi D Perrier Pharmacokinetics 1982 Marcel Dekker New York 1 43
27. RJ Gray TM Bateman LS Czer C Conklin JM Matloff Use of esmolol in hypertension after cardiac surgery Am J Cardiol 56 1985 49F 56F